Globus Medical To Participate At September Investor Events

Globus Medical, Inc. (NYSE:GMED), a leading spinal implant manufacturer, today announced the company will present at investor events upcoming in September 2012.

Richard Baron, Senior Vice President and CFO will be presenting at the Stifel Nicolaus 2012 Healthcare Conference on Thursday, September 6th, 2012 in Boston, Massachusetts at 2:40 PM ET. Interested institutional investors that wish to schedule a meeting should contact Stifel Nicolaus.

David Paul, Chairman and CEO and Richard Baron, Senior Vice President and CFO will be presenting at the Morgan Stanley Global Healthcare Conference in New York City, New York on Monday, September 10, 2012 at 4:10 PM ET. Interested institutional investors that wish to schedule a meeting should contact Morgan Stanley.

About Globus Medical, Inc.

Globus Medical, Inc. is a leading spinal implant manufacturer and is based in Audubon, Pennsylvania. The company was founded in 2003 by an experienced team of spine professionals with a shared vision to create products that enable spine surgeons to promote healing in patients with spinal disorders. Additional information can be accessed at www.globusmedical.com.

Safe Harbor Statements

“Safe Harbor” statements under the Private Securities Litigation Reform Act of 1995: This press release contains estimates and forward-looking statements. All statements other than statements of historical fact contained in this press release are forward-looking statements. The estimates and forward-looking statements contained in this press release are based mainly on our current expectations and estimates of future events and trends, which affect or may affect our businesses and operations. Although we believe that these estimates and forward-looking statements are based upon reasonable assumptions, they are subject to numerous risks and uncertainties and are made in light of information currently available to us as of the date of this presentation. Many important factors may adversely affect our results as indicated in forward-looking statements. For a discussion of some of the important factors that could affect our results, you should refer to the disclosure contained in our prospectus file with the Securities and Exchange Commission on August 3, 2012, as amended, including the sections labeled “Risk Factors,” “Cautionary Note Concerning Forward-Looking Statements,” and “Management's Discussion and Analysis of Financial Condition and Results of Operations.” Additional information will also be set forth in our quarterly report on Form 10-Q that will be filed for the quarter ended June 30, 2012, which should be read in conjunction with these financial results. These documents may be obtained by visiting our Investor Relations website at http://investors.globusmedical.com or the Securities and Exchange Commission's website at www.sec.gov.

Moreover, we operate in an evolving environment. New risk factors and uncertainties emerge from time to time and it is not possible for us to predict all risk factors and uncertainties, nor can we assess the impact of all factors on its business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.

1 2 Next › Last »